U.S. RESEARCH ROUNDUP-Colgate-Palmolive, McKesson, Microsoft July 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Colgate-Palmolive, McKesson and Microsoft, on Tuesday. HIGHLIGHTS * Colgate-Palmolive Co CL.N : TD Cowen initiates coverage with buy rating; PT $110 * DR Horton Inc DHI.N : JP Morgan raises target price to $180 from $163 * IQVIA Holdings Inc IQV.N : Baird raises target price to $251 from $235 * McKesso

U.S. RESEARCH ROUNDUP- Mastercard, Metagenomi, Ziff Davis May 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Mastercard, Metagenomi and Ziff Davis, on Thursday. HIGHLIGHTS * Community Healthcare Trust Inc CHCT.N : Piper Sandler cuts to neutral from overweight * Mastercard Inc MA.N : JP Morgan cuts target price to $510 from $520 * Metagenomi Inc MGX.O : JP Morgan cuts to neutral from overweight * Parsons Corp PSN.N

U.S. RESEARCH ROUNDUP- Air Products and Chemicals, Geron, PayPal May 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Air Products and Chemicals, Geron and PayPal, on Wednesday. HIGHLIGHTS * 3M Co MMM.N : RBC raises target price to $87 from $78 * Air Products and Chemicals Inc APD.N : TD Cowen raises target price to $320 from $305 * Crescent Energy Co CRGY.N : Gerdes Energy Research raises to buy from neutral * Gero

Clorox Co reports results for the quarter ended in March - Earnings Summary Clorox Co CLX.N reported a quarterly adjusted loss of 41 cents​​ per share for the quarter ended in March, lower than the same quarter last year, when the company reported EPS of $1.51. The mean expectation of sixteen analysts for the quarter was for earnings of $1.37 per share.

BUZZ-PREVIEW: Clorox seen reporting quarterly earnings, rev dip ** Shares in bleach maker Clorox CLX.N down 0.7% on Tuesday ahead of fiscal Q3 report due after market close ** Analysts on avg see CLX reporting adj EPS of $1.37 vs $1.51 in the year-ago quarter on rev of $1.87 bln, which would be down ~2% y/y from $1.915 bln, according to LSEG ** In